Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Jerash Holdings (US) (JRSH) EBT (2016 - 2025)

Historic EBT for Jerash Holdings (US) (JRSH) over the last 10 years, with Q3 2025 value amounting to $633059.0.

  • Jerash Holdings (US)'s EBT fell 1783.0% to $633059.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year increase of 17153.25%. This contributed to the annual value of $1.2 million for FY2025, which is 15599.76% up from last year.
  • Per Jerash Holdings (US)'s latest filing, its EBT stood at $633059.0 for Q3 2025, which was down 1783.0% from $652462.0 recorded in Q2 2025.
  • Over the past 5 years, Jerash Holdings (US)'s EBT peaked at $5.5 million during Q3 2021, and registered a low of -$4.0 million during Q1 2024.
  • Over the past 5 years, Jerash Holdings (US)'s median EBT value was $770426.0 (recorded in 2024), while the average stood at $933889.6.
  • Per our database at Business Quant, Jerash Holdings (US)'s EBT surged by 192925.08% in 2021 and then plummeted by 246136.79% in 2024.
  • Jerash Holdings (US)'s EBT (Quarter) stood at $2.3 million in 2021, then tumbled by 47.75% to $1.2 million in 2022, then tumbled by 77.72% to $270705.0 in 2023, then surged by 68.46% to $456028.0 in 2024, then soared by 38.82% to $633059.0 in 2025.
  • Its last three reported values are $633059.0 in Q3 2025, $652462.0 for Q2 2025, and $1.3 million during Q1 2025.